Fibrate
Fenofibrate
Brand names: Lipantil, Supralip, Fenogal
Adult dose
Dose: 160mg OD with food (formulations vary 67–267mg)
Route: PO
Frequency: OD
Dose adjustments
Renal
Reduce in CKD; avoid if eGFR <30
Clinical pearls
- Severe hypertriglyceridaemia
- Mild creatinine rise typical and reversible — usually NOT a reason to stop
Contraindications
- Severe renal/hepatic impairment
- Gallbladder disease
- Pancreatitis (unless 2° to severe hyperTG)
- Pregnancy/breastfeeding
Side effects
- Myopathy
- GI upset
- Headache
- Cholelithiasis
- Mild rise in serum creatinine
Interactions
- Statins (myopathy — avoid combination if possible; if needed use fenofibrate, not gemfibrozil)
- Warfarin (raised INR)
- Ciclosporin (renal toxicity)
Monitoring
- Lipids
- LFTs
- U&E
- CK if symptoms
Reference: BNF; NICE CG181; https://bnf.nice.org.uk/drugs/fenofibrate/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines